0001901599-24-000001.txt : 20240521 0001901599-24-000001.hdr.sgml : 20240521 20240520173453 ACCESSION NUMBER: 0001901599-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240521 DATE AS OF CHANGE: 20240520 EFFECTIVENESS DATE: 20240521 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SANIA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001901599 ORGANIZATION NAME: IRS NUMBER: 873369273 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-513793 FILM NUMBER: 24966047 BUSINESS ADDRESS: STREET 1: C/O SANIA RX LTD, WATERFRONT BUILDING STREET 2: MANBRE WHARF CITY: LONDON STATE: X0 ZIP: W6 9RH BUSINESS PHONE: 011442033988924 MAIL ADDRESS: STREET 1: C/O SANIA RX LTD, WATERFRONT BUILDING STREET 2: MANBRE WHARF CITY: LONDON STATE: X0 ZIP: W6 9RH D 1 primary_doc.xml X0708 D LIVE 0001901599 SANIA THERAPEUTICS, INC. C/O SANIA RX LTD, WATERFRONT BUILDING MANBRE WHARF LONDON X0 UNITED KINGDOM W6 9RH 011442033988924 DELAWARE None None Corporation true 2021 Andrew Murray C/O SANIA RX LTD, WATERFRONT BUILDING Manbre Wharf London X0 UNITED KINGDOM W6 9RH Executive Officer Director Joseph Korff C/O SANIA RX LTD, WATERFRONT BUILDING Manbre Wharf London X0 UNITED KINGDOM W6 9RH Director Robert Brownstone C/O SANIA RX LTD, WATERFRONT BUILDING Manbre Wharf London X0 UNITED KINGDOM W6 9RH Director Mark Evans C/O SANIA RX LTD, WATERFRONT BUILDING Manbre Wharf London X0 UNITED KINGDOM W6 9RH Director Biotechnology Decline to Disclose 06b false 2024-05-06 false true true false 0 7500000 4999995 2500005 false 4 0 0 0 false SANIA THERAPEUTICS, INC. /s/ Andrew Murray Andrew Murray Chief Executive Officer 2024-05-20